Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 16 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Oruka Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q2 2021
- Shares held
- 1.53M
- +335.0K (+28.1%) vs. Q2 2021
- Total value
- $4.53M
- +$361.0K (+8.7%) vs. Q2 2021
- New holders
- 6
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 255 | $7.05B |
| Q1 2026 | 184 | $2.55B |
| Q4 2025 | 143 | $1.60B |
| Q3 2025 | 105 | $875.8M |
| Q2 2025 | 81 | $386.0M |
| Q1 2025 | 71 | $326.1M |
| Q4 2024 | 66 | $606.6M |
| Q3 2024 | 42 | $604.2M |
| Q2 2024 | 32 | $49.4M |
| Q1 2024 | 23 | $12.7M |
| Q4 2023 | 25 | $12.7M |
| Q3 2023 | 21 | $6.55M |
| Q2 2023 | 23 | $5.75M |
| Q1 2023 | 26 | $5.02M |
| Q4 2022 | 22 | $6.19M |
| Q3 2022 | 25 | $4.58M |
| Q2 2022 | 24 | $4.17M |
| Q1 2022 | 22 | $2.60M |
| Q4 2021 | 21 | $2.41M |
| Q3 2021 | 19 | $4.53M |
| Q2 2021 | 17 | $4.16M |
| Q1 2021 | 17 | $3.20M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Oruka Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 441,945 | $1.31M | 0.13% | +311,550+238.9% | Added |
| Vanguard Group Inc | 417,258 | $1.24M | 0.00% | +18,751+4.7% | Added |
| BlackRock Inc. | 268,394 | $795.0K | 0.00% | −5,048−1.8% | Reduced |
| Susquehanna International Group, LLP | 110,035 | $326.0K | 0.00% | +8,288+8.1% | Added |
| Geode Capital Management, LLC | 95,358 | $282.0K | 0.00% | +7,699+8.8% | Added |
| State Street Corp | 69,937 | $207.0K | 0.00% | +900+1.3% | Added |
| Tekla Capital Management LLC | 32,461 | $96.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 29,007 | $86.0K | 0.00% | −23,179−44.4% | Reduced |
| Northern Trust Corp | 17,517 | $52.0K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 16,715 | $49.0K | 0.01% | +16,715 | New |
| Millennium Management LLC | 15,874 | $47.0K | 0.00% | +15,874 | New |
| Minerva Advisors LLC | 10,000 | $30.0K | 0.02% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 2,341 | $7.00K | 0.00% | +2,272+3,292.8% | Added |
| Simplex Trading, LLC | 1,270 | $4.00K | 0.00% | +1,270 | New |
| Parallel Advisors, LLC | 244 | $1.00K | 0.00% | +244 | New |
| Bank of America Corp | 105 | $0 | 0.00% | +74+238.7% | Added |
| Wells Fargo & Company | 88 | $0 | 0.00% | −66−42.9% | Reduced |
| Advisor Group Holdings, Inc. | 107 | $0 | 0.00% | −50−31.8% | Reduced |
| Morgan Stanley | 17 | $0 | 0.00% | +17 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,918−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,846−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,365−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −133−100.0% | Sold out |